课题基金 / 基金详情

Elucidating the molecular mechanisms that control Muller glia activation in the retina

Elucidating the molecular mechanisms that control Muller glia activation in the retina
阐明控制视网膜穆勒胶质细胞激活的分子机制
批准号:
RGPIN-2017-06500
负责人:
Schuurmans, Carol
金额:
$2.91万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Schuurmans, Carol的其他基金

相似基金

相关文献

中文摘要
翻译
概述:神经胶质细胞具有非凡的功能,既可以作为中枢神经系统的分化支持细胞,也可以作为常驻干细胞,在产生新的神经元之前经历去分化和增殖。动员胶质细胞成为干细胞样细胞是冷血脊椎动物(变温动物)(如鱼和青蛙)对眼睛生长、受伤或疾病的自然反应。相比之下,包括哺乳动物在内的温血脊椎动物(恒温动物)的神经胶质动员要有限得多。我们研究了小鼠视网膜中的神经胶质细胞活化,其中Muller神经胶质(MG)是干细胞的潜在来源。然而,通过MG自我修复机制的组织再生在恒温动物中并不容易发生。相反,MG对恒温动物损伤的有利反应是反应性胶质瘤,这是一种神经保护反应,可伴随细胞毒性作用。******为了解释哺乳动物MG是如何选择继续作为分化的支持细胞,作为干细胞重新进入细胞周期,或经历反应性胶质瘤的,我们重点研究了锌指转录因子Zac1。我们发现MG在Zac1零突变小鼠中发生了非损伤性胶质瘤。Zac1是一个母体印迹基因,是共调控基因的印迹基因网络(IGN)的一部分。因此,我们假设Zac1维持MG处于静止分化状态,通过IGN阻止反应性胶质瘤和可能的干细胞修复。为了验证这一假设,我们将:******目标1。评估Zac1在维持MG分化表型中的正常作用。我们通过描述Zac1突变MG的命运和评估它们对非损伤诱导信号的反应来评估Zac1在维持未损伤眼中分化MG命运中的功能。* * *的目标2。探讨Zac1在MG损伤反应中的作用。为了确定Zac1是否参与损伤依赖性MG反应,我们评估了Zac1在各种应激源下的表达,并询问Zac1过表达是否在MG中具有保护作用。* * *的目标3。确定Zac1是否通过IGN维持成熟的MG表型。为了检验Zac1是否通过IGN维持MG处于分化状态,我们研究了Zac1突变MG和损伤模型中IGN基因的表达,并通过功能丧失和功能获得研究进行IGN功能测试。******影响:该项目将增强我们对MG生物学的基础知识,并将其应用于干细胞生物学和组织再生的一般领域。HQP将接触到创新的、最先进的技术,这将使他们在当今的知识经济中具有竞争力
英文摘要
Overview: Glial cells have an extraordinary ability to function either as differentiated support cells in the central nervous system, or as resident stem cells, undergoing de-differentiation and proliferation before giving rise to new neurons. Mobilization of glial cells to become stem cell-like is a natural response to eye growth, injury or disease in cold-blooded vertebrates (ectotherms), such as fish and frogs. In contrast, glial mobilization is much more limited in warm-blooded vertebrates (endotherms), including mammals. We study glial cell activation in the murine retina, where Muller glia (MG) are a potential source of stem cells. However, tissue regeneration via a MG self-healing repair mechanism does not occur readily in endotherms. Instead, the favored response of MG to injury in endotherms is reactive gliosis, a neuroprotective response that can have accompanying cytotoxic effects.******To decipher how mammalian MG make the choice to either remain as differentiated support cells, re-enter the cell cycle as stem cells, or undergo reactive gliosis, we focus on the zinc finger transcription factor Zac1. We found that MG undergo injury-independent gliosis in Zac1 null mutant mice. Zac1 is a maternally imprinted gene and part of an imprinted gene network (IGN) of co-regulated genes. We thus hypothesize that Zac1 maintains MG in a quiescent, differentiated state, acting via the IGN to prevent reactive gliosis and possibly stem cell-repair. To test this hypothesis we will:******Aim 1. Assess the normal role of Zac1 in maintaining a differentiated MG phenotype. We assess Zac1 function in maintaining a differentiated MG fate in the uninjured eye by characterizing the fate of Zac1 mutant MG and by assessing their responsiveness to non-injury inductive cues.***Aim 2. Examine the role of Zac1 in the MG injury response. To determine whether Zac1 participates in injury-dependent MG responses, we assess Zac1 expression in response to various stressors, and ask whether Zac1 overexpression is protective in MG. ***Aim 3. Determine whether Zac1 acts through the IGN to maintain a mature MG phenotype. To test whether Zac1 acts through the IGN to maintain MG in a differentiated state, we study the expression of IGN genes in Zac1 mutant MG and injury models, and perform IGN functional tests with loss- and gain-of-function studies.******Impact: This project will enhance our fundamental knowledge of MG biology, with applications to the general field of stem cell biology and tissue regeneration. HQP will be exposed to innovative, state-of-the-art techniques that will allow them to be competitive in today's knowledge-based economy.**
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the molecular mechanisms that control Muller glia activation in the retina
  • 批准号:
    RGPIN-2017-06500
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $5.83万
  • 财政年份:
    2022
  • 负责人:
    Schuurmans, Carol
  • 依托单位:
Elucidating the molecular mechanisms that control Muller glia activation in the retina
  • 批准号:
    RGPIN-2017-06500
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2021
  • 负责人:
    Schuurmans, Carol
  • 依托单位:
Elucidating the molecular mechanisms that control Muller glia activation in the retina
  • 批准号:
    RGPIN-2017-06500
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2020
  • 负责人:
    Schuurmans, Carol
  • 依托单位:
Elucidating the molecular mechanisms that control Muller glia activation in the retina
  • 批准号:
    RGPIN-2017-06500
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.91万
  • 财政年份:
    2019
  • 负责人:
    Schuurmans, Carol
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: